NABEL ELIZABETH G 4
4 · Lyell Immunopharma, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
NABEL ELIZABETH G
Director
Transactions
- Award
Option (right to buy)
2025-05-15+130,000→ 130,000 totalExercise: $0.40Exp: 2035-05-14→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following May 15, 2025 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of May 15, 2025, subject to the Reporting Person providing continuous service through such date.